Nephros (NasdaqCM:NEPH) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsAnthony Vendetti - Executive Managing Director of ResearchJudy Krandel - CFOKirin Smith - PresidentRobert Banks - President and CEOConference Call ParticipantsNone - AnalystOperatorGood afternoon, everyone, and welcome to the Nephros, Inc. fourth quarter 2025 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressin ...

Nephros (NasdaqCM:NEPH) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsAnthony Vendetti - Executive Managing Director of ResearchJudy Krandel - CFOKirin Smith - PresidentRobert Banks - President and CEOConference Call ParticipantsNone - AnalystOperatorGood afternoon, everyone, and welcome to the Nephros, Inc. fourth quarter 2025 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressin ...

Nephros (NasdaqCM:NEPH) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker3Good afternoon, everyone, and welcome to the Nephros, Inc. fourth quarter 2025 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star and then one on your touchtone telephones. To w ...

Core Insights - Nephros, Inc. reported a 33% year-over-year increase in full-year net revenue, reaching $18.8 million, and a 22% increase in fourth-quarter net revenue to $4.7 million, marking the highest quarterly revenue in the company's history [1][4][3] - The company achieved positive net income for the second consecutive year, with a net income of $1.2 million for the full year and $62,000 for the fourth quarter [1][10] Financial Performance - Full-year net revenue for 2025 was $18.8 million, up from $14.2 million in 2024, representing a 33% increase [4] - Fourth-quarter net revenue was $4.7 million, compared to $3.9 million in the same quarter of 2024, an increase of 22% [4] - Net income for the year was $1.2 million, compared to $74,000 in 2024, while fourth-quarter net income was $62,000, down from $349,000 in the previous year [10] - Adjusted EBITDA for the year was $1.6 million, compared to $548,000 in 2024, while for the fourth quarter, it was approximately $131,000, down from $481,000 in the same period of 2024 [11] Cost and Expenses - Cost of goods sold for the year was $7.2 million, up from $5.4 million in 2024, a 32% increase, while for the fourth quarter, it was $2 million, compared to $1.4 million in the same quarter of 2024, a 41% increase [5] - Selling, general, and administrative expenses for the year were $9 million, up from $7.7 million in 2024, a 17% increase, and for the fourth quarter, these expenses were approximately $2.3 million, compared to $1.9 million in 2024, a 24% increase [7] - Research and development expenses for the year were $1.3 million, compared to $0.9 million in 2024, and for the fourth quarter, they were $0.4 million, up from $0.3 million in the same period of 2024, a 57% increase [8] Strategic Developments - The company has focused on three growth pillars: Products, Service, and Education, which have driven revenue gains [3] - Nephros expanded its service offerings and launched the Nephros Water Institute to enhance its authority in waterborne pathogen mitigation and facility water safety [3] - The company extended its long-term supply agreement with Medica, ensuring continuity of supply and supporting sustained growth [3]

Core Insights - Nephros, Inc. reported a significant increase in net revenue, achieving $18.8 million for the fiscal year 2025, a 33% increase year-over-year, and $4.7 million for the fourth quarter, up 22% year-over-year [1][5][7] - The company has achieved positive net income for the second consecutive year, with net income of $1.2 million for the year and $62,000 for the fourth quarter [12][7] Financial Performance - For the fiscal year ended December 31, 2025, net revenue was $18.8 million compared to $14.2 million in 2024, marking a 33% increase [5][7] - Fourth-quarter net revenue was $4.7 million, up from $3.9 million in the same quarter of 2024, representing a 22% increase [5][7] - The increase in revenue was driven by higher programmatic revenue, strong reorder activity, and growth in the emergency response business [5][7] Cost and Expenses - Cost of goods sold for the year was $7.2 million, an increase of 32% from $5.4 million in 2024 [6] - Selling, general, and administrative expenses rose to $9 million for the year, a 17% increase from $7.7 million in 2024, primarily due to higher bonuses and sales commissions [9] - Research and development expenses increased to $1.3 million for the year, up from $0.9 million in 2024, reflecting a 57% increase in the fourth quarter [10] Profitability Metrics - Gross margin for the year remained stable at 62%, while the fourth-quarter gross margin decreased to 58% from 64% in the previous year [6][7] - Adjusted EBITDA for the year was $1.6 million, compared to $0.5 million in 2024, while fourth-quarter adjusted EBITDA was approximately $131,000, down from $481,000 in the same quarter of 2024 [13][7] Strategic Developments - The company has focused on three growth pillars: Products, Service, and Education, which have contributed to its revenue growth [4] - Nephros launched the Nephros Water Institute to enhance its authority in waterborne pathogen mitigation and facility water safety, aiming to strengthen customer engagement and long-term demand [4] Cash Position - As of December 31, 2025, Nephros had cash and cash equivalents of approximately $5.4 million, an increase from $3.8 million at the end of 2024 [13]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or Other Jurisdiction of Incorporation or Organization) Delaware 13-3971809 (I.R.S. Employer Identification No.) 380 Lackawanna Place South Orange, NJ 07079 (Address of Principal Executive Offices) For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For t ...

Core Viewpoint - Nephros, Inc. will announce its fourth-quarter financial results on March 12, 2026, and will host a conference call to discuss these results the same day at 4:30 PM ET [1]. Company Information - Nephros is a water technology company focused on providing filtration solutions for medical and commercial markets, emphasizing an integrated approach to water safety and quality [3]. - The company aims to enhance the human relationship with water through innovative filtration products and services, as well as water-quality education [3]. Conference Call Details - Participants can join the conference call via domestic access at 1 (844) 808-7106 and international access at 1 (412) 317-5285 [2]. - An audio archive of the call will be available shortly after the event on the Nephros Investor Relations page, with a replay accessible until March 19, 2026 [2].

Core Viewpoint - Nephros, Inc. will announce its fourth-quarter financial results on March 12, 2026, after market close, and will host a conference call at 4:30 PM ET on the same day [1]. Group 1: Financial Results Announcement - The fourth-quarter financial results will be filed on March 12, 2026, after market close [1]. - A conference call will take place on the same day at 4:30 PM ET for discussing the results [1]. - Participants can join the call using domestic access at 1 (844) 808-7106 or international access at 1 (412) 317-5285 [1]. Group 2: Call Replay Information - An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page [2]. - A replay of the call can be accessed until March 19, 2026, using the number 1 (855) 669-9658 for domestic callers and 1 (412) 317-0088 for international callers, with the replay access code: 3018234 [2]. Group 3: Company Overview - Nephros is focused on improving the human relationship with water through accessible technology [2]. - The company provides innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety [2]. - Nephros serves customers in both medical and commercial markets, offering proactive and emergency solutions for water management [2].

Core Insights - Nephros, Inc. has announced its entry into the Puerto Rican market, focusing on high-need applications such as ice machines, drinking fountains, bottle fillers, and sterile processing environments [1][3] - The company aims to address unmet needs in waterborne pathogen and contaminant control in Puerto Rico, estimating a market opportunity of $10 million across various sectors [3][4] Company Strategy - Nephros differentiates itself by providing advanced filtration solutions with faster service and local-language support, targeting a region that has been underserved by premium filtration providers [2][5] - The company's entry into Puerto Rico aligns with its broader growth strategy to expand into adjacent markets beyond traditional patient care, including hospitality and foodservice [5] Market Potential - The estimated market breakdown in Puerto Rico includes: - Healthcare: $3 million - Foodservice: $3 million - Hotels: $1 million - Other Hospitality: $1 million - Service Contracts & Replacements: $1 million [8] Product Offerings - Nephros plans to offer localized services, including rapid response and fulfillment from a dedicated inventory network, on-site installation, scheduled filter replacements, and customer support in Spanish [9] - The filtration solutions will focus on microbial control and regulated drinking water contaminants such as lead and PFAS [9]

Core Insights - Nephros, Inc. has launched the Nephros Water Institute to enhance its leadership in industry education and drive long-term growth in water quality solutions [1][3] Group 1: Educational Initiatives - In 2025, Nephros expanded its national education efforts, reaching nearly 1,000 professionals through public webinars, national speaking engagements, and tailored trainings [2] - The educational programming focused on critical areas such as ASHRAE 514 compliance, AAMI ST108 sterility standards, and emergency preparedness for compromised water events [2] - The establishment of the Nephros Water Institute aims to provide structured, evidence-based education to stakeholders responsible for water safety and regulatory readiness [3] Group 2: Leadership Statements - Brianne McGuire emphasized the need for practical education to address the fundamental gap in understanding water safety risks [3] - Robert Banks stated that the Nephros Water Institute will provide leaders with accurate information to make safer decisions regarding water systems, highlighting education as a key component of the company's commitment to water safety [4] Group 3: Future Plans - Nephros plans to expand its educational offerings in 2026 with a full calendar of monthly webinars and product spotlights [4]